Remdesivir ni imiti igabanya ubukana bwa virusi. Yabanje gukorwa mu myaka icumi ishize kugirango ivure hepatite C na virusi imeze nkubukonje yitwa virusi yubuhumekero (RSV). Remdesivir ntabwo yari uburyo bwiza bwo kuvura indwara. Ariko yerekanye amasezerano yo kurwanya izindi virusi.

Abashakashatsi bapimishije remdesivir mu bigeragezo byo kwa muganga mu gihe cya Ebola. Indi miti yiperereza yakoze neza, ariko yerekanwe ko ifite umutekano kubarwayi. Ubushakashatsi bwakorewe mu ngirabuzimafatizo no ku nyamaswa bwagaragaje ko remdesivir yagize akamaro kanini mu kurwanya virusi mu muryango wa coronavirus, nka Syndrome yo mu Burasirazuba bwo Hagati (MERS) na Syndrome de Severe Acute Respiratory Syndrome (SARS).

Remdesivir ikora ihagarika umusaruro wa virusi. Coronavirus ifite genome zigizwe na aside ribonucleic (RNA). Remdesivir ibangamira imwe mumisemburo yingenzi virusi ikenera kwigana RNA. Ibi birinda virusi kugwira.

Abashakashatsi batangiye igeragezwa rya virusi ya virusi muri Gashyantare 2020 kugira ngo barebe niba remdesivir ishobora gukoreshwa mu kuvura SARS-CoV-2, coronavirus itera COVID-19. Muri Mata,ibisubizo hakiri kareyerekanye ko remdesivir yihutiye gukira abarwayi bari mubitaro bafite COVID-19 ikomeye. Yabaye ibiyobyabwenge byambere byabonye uruhushya rwo gukoresha byihutirwa n’ikigo cy’Amerika gishinzwe ibiryo n’ibiyobyabwenge (FDA) cyo kuvura abantu bari mu bitaro barwaye COVID-19.

Abashakashatsi ubu barangije igeragezwa, rizwi ku izina rya Adaptive COVID-19 yo kuvura (ACTT-1). Ubushakashatsi bwatewe inkunga n'ikigo cy'igihugu gishinzwe allergie n'indwara zanduza (NIAID). Raporo yanyuma yagaragaye muriIkinyamakuru gishya cy’ubuvuziku ya 8 Ukwakira 2020.